AMRX vs BB · P/E 44, rev $2.79B vs P/E 117, rev $549.1M
Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) versus BlackBerry Ltd (BB) — a side-by-side from cached financials, not a winner call.
Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) is a drug manufacturers - specialty & generic company listed on NASDAQ.
BlackBerry Ltd (BB) is a software - infrastructure company listed on US.
Latest reported AMRX revenue for 2024-12-31 was $2.79B. Net income was -$73.9M. Revenue was up 16.7% from 2023-12-31 to 2024-12-31. AMRX currently screens at market cap $5.19B and trailing P/E 44.0.
Latest reported BB revenue for 2026-02-28 was $549.1M. Net income was $53.2M. Revenue was up 2.7% from 2025-02-28 to 2026-02-28. BB currently screens at market cap $6.14B and trailing P/E 116.5.
AMRX currently screens at market cap $5.19B and trailing P/E 44.0. BB currently screens at market cap $6.14B and trailing P/E 116.5.
Not investment advice. Open the AMRX and BB stock pages for the full models.
Not investment advice.